1. Ghuman N, Campbell P, White WB. Role of ambulatory and home blood pressure recording in clinical practice. Curr Cardiol Rep. 2009; 11:414–421.
2. Kim SG. Clinical implications of ambulatory and home blood pressure monitoring. Korean Circ J. 2010; 40:423–431.
3. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004; 18:139–185.
4. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005; 111:697–716.
5. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25:1105–1187.
6. Myers MG, Valdivieso M, Kiss A. Optimum frequency of office blood pressure measurement using an automated sphygmomanometer. Blood Press Monit. 2008; 13:333–338.
7. Wright JM, Mattu GS, Perry TL Jr, et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit. 2001; 6:161–165.
8. O'Brien E, Petrie J, Littler W, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993; 11:S43–S63.
9. O'Brien E, Pickering T, Asmar R, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit. 2002; 7:3–17.
10. Crippa G, Ragni G, Venturi C, Arrigoni E, Pancotti D. Repeated office blood pressure (ROBP) measurement for the evaluation of antihypertensive treatment efficacy. Am J Hypertens. 2005; 18(S4):28A–29A.
11. Crippa G, Sverzellati E, Venturi C, Antoniotti P. Repeated office blood pressure measurement by automated device to evaluate blood pressure control. Am J Hypertens. 2003; 16(S1):46A.
12. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, Reboldi G. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Hypertension. 2007; 49:777–783.
13. van der Wel MC, Buunk IE, van Weel C, Thien TA, Bakx JC. A novel approach to office blood pressure measurement: 30-minute office blood pressure vs daytime ambulatory blood pressure. Ann Fam Med. 2011; 9:128–135.
14. Scherpbier-de Haan N, van der Wel M, Schoenmakers G, et al. Thirty-minute compared to standardised office blood pressure measurement in general practice. Br J Gen Pract. 2011; 61:e590–e597.
15. Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the "white coat effect" in routine practice. Am J Hypertens. 2003; 16:494–497.
16. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press Monit. 2006; 11:37–42.
17. Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011; 154:781–788. W289–W290.